Two Sigma Securities’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
+6,099
New +$180K 0.02% 1125
2025
Q3
Sell
-18,769
Closed -$212K 1905
2025
Q2
$212K Buy
+18,769
New +$203K 0.03% 890
2024
Q4
Sell
-15,778
Closed -$182K 2937
2024
Q3
$182K Buy
+15,778
New +$180K ﹤0.01% 2181
2023
Q4
Sell
-13,532
Closed -$158K 3498
2023
Q3
$158K Buy
+13,532
New +$153K ﹤0.01% 2342

Other funds holding ROIV

Two Sigma Securities's ROIV Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Roivant Sciences (ROIV) in Q2 2026: 6,099 shares worth $216K. The stake represents 0.02% of the portfolio and ranks #1125 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ROIV as recently as Q2 2025.

Two Sigma Securities first reported a position in ROIV in Q3 2023 and has held it in 4 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Two Sigma Securities held 6,099 shares of Roivant Sciences worth $216K as of Q2 2026.
  • Roivant Sciences was a new Two Sigma Securities position in Q2 2026.
  • Roivant Sciences made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1125 holding.
  • Two Sigma Securities first reported a position in Roivant Sciences in Q3 2023 and has held it in 4 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.